MedPath

Osteopathic Manipulative Treatment (OMT) on patients with Cervicogenic Headache Pragmatic randomized controlled clinical trial

Not Applicable
Recruiting
Conditions
Secondary Headache Disorders
C10.228.140.546
Registration Number
RBR-10yhrbnz
Lead Sponsor
Escola de Osteopatia de Madrid
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
Not specified
Inclusion Criteria

Age between 18 years and 49 years; Both sexes; Unilateral headache, starting in the posterosuperior region of the neck or occipital region, eventually spreading to the oculofrontotemporal on the symptomatic side; Pain triggered by neck movement and/or positions sustained inadequate; Reduced range of motion in the cervical spine; Pain caused by external pressure at at least one cervical level superior (C0 to C3/C4); Present moderate to severe complaint and/or symptoms, not throbbing and not lacinating; Headache frequency of at least once a week for a minimum period of 3 months; Have a minimum disability score of 20% or more (or that is, 10 points or more on the 0-50 NDI scale; Be able to move independently with or without the use of assistance; Be able to understand enough Portuguese to be able to fill in the questionnaires;

Exclusion Criteria

Other primary headaches Migraine, Tension Headache; Bilateral headaches; Time less than 6 months after surgery on the cervical spine, head or neck; history of cervical injury; upper limbs or region facial; Performing an invasive procedure for pain relief in the last 3 months; Receiving physical therapy, osteopathic or chiropractic treatment in the last 3 months; If you have two or more positive neurological signs consistent with nerve root compression muscle weakness involving a large upper extremity muscle group, decreased upper extremity deep tendon reflex, or decreased or absent pinprick sensation in any upper extremity dermatome; Diagnosis of cervical spinal stenosis; Exhibit these bilateral upper extremity symptoms; Evidence of central nervous system involvement hyperreflexia, sensory disturbances in the hand, hand atrophy, unsteadiness during gait, nystagmus, loss of visual acuity, decreased face sensation, taste alteration, presence of pathological reflex signs; Inflammatory rheumatic diseases eg rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, systemic lupus erythematosus, etc.; Progressive neurological disease e.g. multiple sclerosis, Parkinson's disease, first neuron disease Unstable heart conditions;

Study & Design

Study Type
Intervention
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath